Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies - Wikidata - wikimedia - TriplyDB

Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies

Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies

http://www.wikidata.org/entity/Q28344098

about

Differentiation and selection of hepatocyte precursors in suspension spheroid culture of transgenic murine embryonic stem cells Proteomic analysis of iron overload in human hepatoma cells.Intermediate filaments: a historical perspective Sensitivity and specificity of in situ proximity ligation for protein interaction analysis in a model of steatohepatitis with Mallory-Denk bodies.Increased levels of keratin 16 alter epithelialization potential of mouse skin keratinocytes in vivo and ex vivo.Keratin mutations and intestinal pathology.iTRAQ: a method to elucidate cellular responses to mycotoxin zearalenone.Keratins: guardians of the liver.Absence of keratin 8 confers a paradoxical microflora-dependent resistance to apoptosis in the colon.The human keratins: biology and pathology.Keratins in health and cancer: more than mere epithelial cell markers Cytokeratins as targets for bile acid-induced toxicity.Bile acid-induced Mallory body formation in drug-primed mouse liver.Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease.The keratin cytoskeleton in liver diseases.Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation.Reg-II is an exocrine pancreas injury-response product that is up-regulated by keratin absence or mutation Keratin 8 overexpression promotes mouse Mallory body formation.Keratins modulate colonocyte electrolyte transport via protein mistargeting.Keratin 8 protection of placental barrier function.Intermediate filament cytoskeleton of the liver in health and disease How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.Alcohol induced hepatic degeneration in a hepatitis C virus core protein transgenic mouse model.Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system.The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthful.Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.The role of intracellular protein O-glycosylation in cell adhesion and disease.Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models.Lessons from Animal Models of Cytoplasmic Intermediate Filament Proteins.Formation of Mallory body-like inclusions and cell death induced by deregulated expression of keratin 18.Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation.In vitro production of Mallory bodies and intracellular hyaline bodies: the central role of sequestosome 1/p62.Arsenite induced oxidative damage in mouse liver is associated with increased cytokeratin 18 expression.Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells.Aggregation and loss of cytokeratin filament networks inhibit golgi organization in liver-derived epithelial cell lines.Alleviation mechanisms against hepatocyte oxidative stress in patients with chronic hepatic disorders.p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases.Keratins modulate the shape and function of hepatocyte mitochondria: a mechanism for protection from apoptosis.Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation.

P2860

Q28483972-2125D80B-5A65-49F0-AB9D-39EF9C66DABD Q33231557-FF3F34B2-9878-4087-B4ED-86D012E80681 Q33284286-DE76FE3A-3591-4E9A-B179-63D932D36E55 Q33568040-445A380C-1102-4532-9051-3F55C4E78AAD Q33948498-4555E981-EE39-41B2-A281-6A55A4FC1590 Q33982454-29C4415C-56DD-4720-A762-B6813C1824AB Q34315989-DA212C8E-D8FD-4241-B2ED-09E5C4002095 Q34516417-4ABE61D6-9A03-495F-A00E-31265A01B5F9 Q34534053-CD600A4D-C462-4F45-82F0-320B4032E97E Q34776574-2E897575-CA96-455A-995E-F250781A1343 Q35161934-3C70A61D-115B-4D8F-AD78-044445C12D88 Q35747276-A94E1B05-1868-4245-A311-D59A6E4A3F6F Q35748180-1484DE7E-6F5B-43DB-83D6-EB6297D0FE02 Q35785507-0ADC9289-189B-465D-AC90-0EF38BA480E7 Q35923530-4687EA79-1ABA-40F9-9053-4566E42C2F2A Q35987918-D23FFC18-95A2-46A2-BAB3-EC8EE70C53EF Q36173905-170F08B9-FED4-4856-894F-96C56330AAC6 Q36320550-DDC76077-AAF0-432A-9A57-23F5865241EF Q36322258-16F34537-A4FB-43F0-85A5-A7EA66EE7C60 Q36381432-EF1E363D-D756-41BD-8C90-E7E21A23866B Q36661678-A4884311-188A-4DC6-91CC-681DBF8CBA39 Q36887505-90C8E8E4-E597-4217-897F-3219711B11D1 Q37684034-1EBA5E13-45BF-43EC-BAD5-B7A14CDEB9AC Q37824547-949CA559-C451-4708-A159-1355D4E7B092 Q37863129-A2023B62-D28C-4AC6-8F92-C6E9A106E048 Q37863134-6581612D-789B-4123-A86C-4D0A05B73FE9 Q37863136-6B017ECD-63BF-44D2-B50D-E323DE36645D Q38095924-A8EC67EA-7851-4524-82CC-06B743460A39 Q38165139-5E384F25-1475-42B7-914F-3D43D7C9B406 Q39094595-A5F02251-0FD6-4DD2-8874-B571D4B6C1CC Q39661913-0097E957-0CA2-433F-B70D-9CB3A1E69548 Q39958828-6CEB6DF6-4E92-4DA7-9304-245006BF3AF1 Q40096749-57D03282-E70E-42E8-B997-7197DCDE81CD Q40162900-0A7AFD45-2ED2-4671-8DFA-73BF25D05990 Q40530480-36182940-B9C7-4031-9801-7C1F768303C2 Q40611378-82762443-6C3A-4B26-8517-22BAF63705FF Q42175210-2287A93B-14AA-44DB-AA9E-A9AEB3D6A3B3 Q42184099-548A4561-9EE4-465A-B816-8C9FA9355029 Q42616331-FE9EBE11-0CF8-4DD3-8D7E-19DCFD5BB9D7 Q42948122-822631BD-3338-43C4-B330-AE766970CFF2

P2860

Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies

http://www.wikidata.org/entity/Q28344098

description

2000 nî lūn-bûn

@nan

2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Cytokeratin 8 protects from he ...... tocytes to form Mallory bodies

@ast

Cytokeratin 8 protects from he ...... tocytes to form Mallory bodies

@en

Cytokeratin 8 protects from he ...... tocytes to form Mallory bodies

@nl

type

label

Cytokeratin 8 protects from he ...... tocytes to form Mallory bodies

@ast

Cytokeratin 8 protects from he ...... tocytes to form Mallory bodies

@en

Cytokeratin 8 protects from he ...... tocytes to form Mallory bodies

@nl

prefLabel

Cytokeratin 8 protects from he ...... tocytes to form Mallory bodies

@ast

Cytokeratin 8 protects from he ...... tocytes to form Mallory bodies

@en

Cytokeratin 8 protects from he ...... tocytes to form Mallory bodies

@nl

P1433

Q28344098-92C4A757-8C4F-4384-8893-E104C711B0F0

P1476

Q28344098-5D126605-DACD-4EB4-8015-83462F89FC20

P2093

Q28344098-0FB8D8D1-CFB6-4441-81F3-0037FAD3FB8B

Q28344098-22B42F3E-8654-45EA-A6B0-1102BE36D323

Q28344098-6D3BA294-05C0-4FFB-A009-F341AA26E849

Q28344098-B2CF0F6E-0488-4F1E-9CEB-6568906F5193

Q28344098-BF2077F2-3E06-4475-B34C-7AC6D6640EDC

Q28344098-D094AF68-B3B1-4B77-9A61-7687EB3BEC3D

Q28344098-D5C75E83-2D53-427E-BC2B-F54B88F55357

P2860

Q28344098-0351813E-4854-4849-BE42-EAF975A8468E

Q28344098-0DF613BA-82BB-4576-A017-CDEF3239CB8C

Q28344098-0EAE0BE0-946A-4476-ABCE-B98F8776BB63

Q28344098-138D18CA-E131-4EC5-A75E-5F9300CF7E46

Q28344098-1591B473-A916-4905-94B9-D4D2E8A6775D

Q28344098-15AACBBD-B8D5-44CC-97F4-99C3F4FAA7F6

Q28344098-172458D0-CC4C-4743-9E58-E168C5CE669A

Q28344098-17B4870F-CF88-4F8A-B7C0-A18125612727

Q28344098-1D4DBB63-B22C-462D-9268-C8C065782777

Q28344098-1E030E30-643C-4962-A09A-4878BA34147B

P304

Q28344098-EA9FF654-BB17-49EC-822E-E825263C4D00

P31

Q28344098-7FB448B8-882B-4581-9EF8-9277CCEE2A87

P356

Q28344098-431BC463-1709-42FE-9C67-64376B6281EF

P407

Q28344098-D6CA59FA-0078-46BE-AE2B-7D82BCE85195

P433

Q28344098-AE198214-4582-4B2C-B8E9-2F9CC69A0EF1

P478

Q28344098-F69B4ED0-5D8E-40F7-AA02-32B940992442

P577

Q28344098-46B6EE2E-D894-4453-ABCB-E64C7A88823C

P5875

Q28344098-7918C7CB-A4B2-4B26-873D-379F9A45DE8D

P698

Q28344098-58ABC3C0-2394-4871-9790-4D73F1725BBA

P921

Q28344098-737BEC60-369E-44F3-9B7D-81186F885579

P932

Q28344098-F45472A9-345D-4704-9D2F-DA5172678CF0

P356

S0002-9440(10)64997-8

P1433

The American Journal of Pathology

P1476

Cytokeratin 8 protects from he ...... tocytes to form Mallory bodies

@en

P2093

C Stumptner

http://www.w3.org/2001/XMLSchema#string

H Baribault

http://www.w3.org/2001/XMLSchema#string

H Denk

http://www.w3.org/2001/XMLSchema#string

K Zatloukal

http://www.w3.org/2001/XMLSchema#string

L G Eshkind

http://www.w3.org/2001/XMLSchema#string

M Lehner

http://www.w3.org/2001/XMLSchema#string

W W Franke

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of human cytokeratin 2, an epidermal cytoskeletal protein synthesized late during differentiation

Suprabasal marker proteins distinguishing keratinizing squamous epithelia: cytokeratin 2 polypeptides of oral masticatory epithelium and epidermis are different

A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

Mutation of human keratin 18 in association with cryptogenic cirrhosis

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

The Mallory body: morphological, clinical and experimental studies (Part 1 of a literature survey)

Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells

The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells

P304

1263-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)64997-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

156

http://www.w3.org/2001/XMLSchema#string

P577

2000-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12565735

http://www.w3.org/2001/XMLSchema#string

P698

10751352

http://www.w3.org/2001/XMLSchema#string

P921

P932

1876873

http://www.w3.org/2001/XMLSchema#string